FGF21 increases metabolic rates under baseline conditions but is dispensable for the resistance to diet-induced obesity (DIO) reported in OPA1 BKO mice (Pereira et al., 2021). This evidence concerns the gene OPA1 and obesity due to melanocortin 4 receptor deficiency.